Box score
Climb Bio, Inc.
Reported $110M sold in a new Form D filed May 4, 2026 (Wellesley Hills, Massachusetts).
- Biggest raise
- $110M filed May 4, 2026
- League
- Bio & Health Biotechnology
- Based in
- Wellesley Hills, Massachusetts
- Season rank
- #13 of 1,121 in the Bio & Health League; #182 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-05-04 | New notice | $110M | $110M | SEC |
| 2024-07-02 | New notice not ranked | $120M | $120M | SEC |
| 2024-07-02 | New notice not ranked | $41.9M | $41.9M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1768446.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Solstice Oncology, Inc. rookie | Bio & Health | $121M |
| 2 | Strand Therapeutics Inc. | Bio & Health | $108M |
| 3 | Alzheon, Inc. | Bio & Health | $78.8M |
| 4 | Ratio Therapeutics, Inc. | Bio & Health | $70M |
| 5 | Superluminal Medicines, Inc. | Bio & Health | $65.5M |
| 6 | Stipple Bio, Inc. | Bio & Health | $65.1M |